analyst day recap strong
get stronger rais est po
upbeat analyst day posit updat yr plan
publish quick take tmo investor meet earlier today
provid addit color follow ceo marc casper bullish comment
recent healthcar conf link expect high expect reiter
outlook focu next guid futur capit deploy
abil leverag increas breadth product servic point
think deliv end result bit ahead expect street forecast
need move higher
recent end market weak seen peer link well potenti macro risk
key topic see troubl horizon cite
better mix scale geograph reach share gain portfolio breadth innov key
differenti factor provid underli support thesi
continu see better core growth given driver along broad strength
end-market increment contribut high-growth acquisit
patheon provid end-to-end offer acquisit
expect growth opportun market share peer call
soft china food market cite food safeti one key driver
continu high growth china due better mix key driver growth china
includ strong posit environ biotech research academ
govern market remain optimist tmo lt outlook china
high-growth emerg market
rais po reiter buy
improv earn outlook maintain ep estimate rais
our-year sale ep forecast adj ep higher
street adj ep vs street
updat guid introduc est top-lin adj
ep estimate driven part higher forecast rais po
still base wacc termin growth rate continu view
core hold investor look solid secular growth
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
contract develop
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
thermo fisher scientif largest
consist analyt instrument lab
equip consum softwar servic
use throughout research drug manufactur
diagnost food consum product safeti
environment test
thermo fisher scientif largest life scienc
tool compani think recent acquisit
complementari technolog higher growth
on-going process improv initi
expand footprint emerg appli
market help grow revenu steadili
line even modestli better
overal tool market deliv low teen ep
compound-annual-growth-rate next sever year
po base dcf model assum wacc termin
growth rate impli multipl approxim ep estim roughli
line compani histor averag given size market leadership matur
stabil compani consum focus busi believ dcf
appropri way valu compani risk price object deal
integr risk lower-than-expect deal synergi slower growth emerg
market price eros lower healthcar util trend soft uptak new
product competit weak fund
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
